Latest South Pacific News

Firebrick Pharma has secured a $102,000 investment from its Philippines strategic partner, Pharma Nutria N.A., Inc., reinforcing its position ahead of the Nasodine nasal spray launch in 2026.

BSP Financial Group reveals the Papua New Guinea Government’s plan to shift accounts to a new state-owned bank, potentially denting BSP’s profits. The bank is evaluating the full impact and possible responses.

Firebrick Pharma reported a substantial increase in Nasodine Nasal Spray revenues in FY25, alongside a widening net loss driven by reduced R&D incentives and increased marketing investments. The company is advancing its international rollout with new licensing deals and board appointments.

Firebrick Pharma has secured an exclusive licensing agreement with Innorini Pte Ltd to distribute Nasodine products across Singapore, Malaysia, Brunei, and Mauritius, aiming to reduce marketing expenses and broaden market access.

BSP Financial Group Limited has reported a robust half-year performance for 1H25, marked by nearly 10% growth in revenue and net profit after tax, alongside a healthy capital position and an increased interim dividend.

BSP Financial Group reported a solid 9.8% increase in net profit after tax for the first half of 2025, driven by strong revenue growth and strategic investments in digital banking. The bank also raised its interim dividend by 11.1%, reflecting confidence in its ongoing modernization efforts.

Firebrick Pharma has published its pivotal Phase 3 trial results for Nasodine nasal spray, confirming its effectiveness and safety in treating the common cold, especially when used early.

Firebrick Pharma has unexpectedly withdrawn its planned share placement, raising questions about its capital strategy amid ongoing product launches.

BSP Financial Group reported a 17% rise in net profit and a 16% dividend increase for 2024, while advancing key digital and SME banking initiatives across the South Pacific.

The Calmer Co. International Limited has secured a FJD2.64 million loan from Fiji Development Bank to acquire its Navua manufacturing site, marking a strategic step to enhance production and market presence in the global kava industry.